Form 4 for BVS Bioventus Inc.
Accepted 2023-03-27 00:00:00 ET · period of report 2023-03-24 · accession 0000899243-23-009758 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-27 | 2023-03-24 | BVS | Singleton Mark Leonard | SVP, CFO | S - Sale | $1.27 | -6,044 | 12.6K | -32% | -$7,676 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-24 | S | D | 6,044 | $1.27 | 12,581 | D | — | — |